FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076921 [Registered on: 18/11/2024] Trial Registered Prospectively
Last Modified On: 04/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Efficacy Of Boswellia serrata Roxb. (Twak and Niryas) on Atyartava (Excessive Menstural Bleeding) 
Scientific Title of Study   A COMPARATIVE STUDY OF SHALLAKI (BOSWELLIA SERRATA ROXB.) TWAK AND NIRYAS W.S.R. TO RAKTAPRADAR.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pragya Mandloi 
Designation  M.D. Scholar, Dravyaguna 
Affiliation  Pt. Khushilal Sharma Ayu. College Bhopal M.P. 
Address  Room No.226, PG Department Of Dravyaguna, Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Science Hills Behind MANIT, Bhopal, Madhya Pradesh, India, 462003

Bhopal
MADHYA PRADESH
462003
India 
Phone  9669048969  
Fax    
Email  mandloipragya43@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vinod Sharma 
Designation  Reader Dravyaguna 
Affiliation  Pt. Khushilal Sharma Ayu. College Bhopal M.P. 
Address  Room No.226, PG Department Of Dravyaguna, Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Science Hills Behind MANIT, Bhopal, Madhya Pradesh, India, 462003

Bhopal
MADHYA PRADESH
462003
India 
Phone  9926379195  
Fax    
Email  Sharmavinod389@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pragya Mandloi 
Designation  M.D. Scholar, Dravyaguna 
Affiliation  Pt. Khushilal Sharma Ayu. College Bhopal M.P. 
Address  Room No.226, PG Department Of Dravyaguna, Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Science Hills Behind MANIT, Bhopal, Madhya Pradesh, India, 462003

Bhopal
MADHYA PRADESH
462003
India 
Phone  9669048969  
Fax    
Email  mandloipragya43@gmail.com  
 
Source of Monetary or Material Support  
Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Bhopal 
 
Primary Sponsor  
Name  Pt. Khushilal Sharma Ayu. College Bhopal M.P. 
Address  Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Science Hills Behind MANIT, Bhopal, Madhya Pradesh, India, 462003  
Type of Sponsor  Other [State Government Ayurveda College and Institute] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pragya Mandloi  Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Bhopal  Opd No.12, Department of Prasuti Tantra and Striroga, Hospital Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Bhopal
Bhopal
MADHYA PRADESH 
09669048969

mandloipragya43@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee, Pt. Khushilal Sharma Government Autonomus Ayurveda College and Institute, Bhopal  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Shallaki twak - Boswellia serrata, Reference: Dhanwantari nighantu, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Shallaki Niryas- Boswellia serrata, Reference: Dhanwantari nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1. Age between Menarche and Menopause
2. Excessive bleeding during menstruation (change of more than 3 soiled pads/day)
3. Passing of large clots.
4. Prolonged Menstrual bleeding (more than 7 days)
5. Excessive bleeding for more than 2 consecutive cycles
6. Intermenstrual Bleeding
 
 
ExclusionCriteria 
Details  1. Intrauterine growth such as Myomas, endometrial polyp etc.
2. Cancer of cervix and or uterus.
3. Hb less than 6 gm %.
4. Any other systemic disorders likely to influence menstrual cycle.
5. Case undergoing treatment for any other serious illness.
6. Woman using an IUCD/ OCP/depot.
7. Venereal disease.
8. Systemic cause mentioned below will also be kept under exclusion criteria:
Severe hypertension,Liver dysfunction,Congestive cardiac failure,Patient having bulky uterus, Patients having bleeding from sites other than uterus,Patients having coagulation disorder 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvment in subjective parameter of menorrhagia as-
1. Bleeding amount in no. of pads
2. Duration of flow or menstrual period (In no. of days)
3. Interval of Menstruation (in no. of days)
4. Pallor (Panduta) (Hb %)
5. Pain (Pain in abdomen / backache)
6. Weakness (Daurabalya)
7. Burning Sensation (Daha)
 
4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Investigation:
Blood: Hb%, TLC, DLC, ESR, CT, BT 
30 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Aim of the study is to provide a simple, safe and herbal drug for patient of Raktapradar and  Evaluation of efficacy of Shallaki niryas (Kunduru) and Shallaki twak kwath.
Participants fulfilling the inclusion criteria will be selected.  Those patients will be selected, who fulfils the criteria of selection and attended the OPD of department of Prasuti tantra and strirog at Pt. Khushilal Sharma Govt. (Auto.) Ayurveda College and Institute Bhopal.  The clinical trial will be taken out on 60 (30 Participants in each group) and they were randomly selected and divided into 2 groups: 
Group A- Study group      
Group B- Study group  
CRITERIA FOR DIAGNOSIS
1. Patient presenting with complains of excessive and irregular menstrual bleeding was selected. 
 2. Including symptoms: Angamarda, vedana, dourbalya, bhrama, murcha, tama, daha, pralap, panduta, tandra, vataj rog.
Assessment criteria: Subjective parameters will be scored as mentioned in specially designed scale and will be compared before and after treatment. 
Objective parameter will also be compared at the same interval. 
The assessment criteria for Raktapradar will be mainly based on: 
[a] Subjective criteria: 1. Bleeding amount in no. of pads   
2. Duration of flow or menstrual period (In no. of days) 
3. Interval of Menstruation (in no. of days) 
4. Pallor (Panduta) (Hb %) 
5. Pain (Pain in abdomen / backache) 
6. Weakness (Daurabalya)
7. Burning Sensation (Daha)
[b]. Objective criteria: Haemoglobin Level (Hb% Level) 
 Investigation: Blood: Hb%, TLC, DLC, ESR, CT, BT
 
Close